1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
  5. > Competitor Analysis: Pim Kinase Inhibitors

Competitor Analysis: Pim Kinase Inhibitors

  • September 2013
  • -
  • La Merie Publishing
  • -
  • 17 pages

Competitor Analysis: Pim Kinase Inhibitors

Product description

The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cancer development and progression. These proteins are constitutively active once transcribed. Pim kinases are critical downstream effectors of the ABL, JAK2, and Flt-3 oncogenes and are required by them to drive tumorigenesis.

The present Competitive Intelligence report about Pim Kinase Inhibitorsprovides a competitor evaluation in the field of small molecule- and siRNA/miRNA-based inhibitors of the Pim Kinase for the treatment of cancer as of September 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of small molecule and siRNA/miRNA inhibitors of the Pim Kinases. In addition, the report lists company-specific R&D pipelines of Pim Kinase inhibitors.

Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Pim Kinase Inhibitors
Competitor Analysis: Pim Kinase Inhibitors

Table of Contents

• Pan-PIM Kinase Inhibitors
• Selective PIM-1 Kinase Inhibitors
• Dual PIM Kinase Inhibitors
• Not Specified PIM Kinase Inhibitors
• Dual Target PIM Kinase Inhibitors
• Corporate Pim Kinase Inhibitor RandD Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sunitinib, developed and marketed as Sutent by Pfizer Inc and previously known as SU11248, is a small-molecule medicine which has to be administered orally and has been proven to be effective in blocking ...

Global Kinase Inhibitors Market Report 2016

Global Kinase Inhibitors Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Kinase Inhibitors Report is a professional and in-depth research report on the world's major regional market conditions of the Kinase Inhibitors industry, focusing on the main regions (North ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.